Press

GLOBAL MINIMALLY INVASIVE NEUROSURGICAL MARKET TO REACH $3.7 BILLION BY 2015

HUNTINGTON BEACH, Calif.-March 9, 2009--(BUSINESS WIRE)--According to a new 2009 report from Life Science Intelligence (LSI), Global Neurosurgical Product Markets, the market for minimally invasive (MI) neurosurgical technologies for intracranial applications is expected to reach $3.7 billion by 2015.

Growth will be strongest in stereotactic radiosurgery and neurovascular embolization.  In stereotactic radiosurgery, growth will be driven by new product introductions that yield better precision and accuracy while improving patient throughput.  Improved accuracy and precision will expand the treatable population, and greater patient throughput will provide an economic incentive for acquiring stereotactic radiosurgical systems.  Upgrades and modules that allow the treatment of extracranial lesions will also boost product sales.

Neurovascular embolization technologies, which include aneurysm coils, arteriovenous malformation (AVM) embolics, and accessories, will also see broader adoption through 2015.  Growth will be driven by the clinical benefits of minimal access, the introduction of advanced technologies that provide better occlusion while resisting coil migration, and increasing use in countries outside of the U.S. and Europe.  The ability to deliver treatment using endovascular access will continue to shift procedure volumes away from surgical clipping for aneurysm patients.  Advanced technologies, such as balloon catheters, stents, and new coil products, are expected to contribute to better clinical outcomes than older systems.  Finally, increasing use in regions outside of the U.S. and Europe, where these technologies are already well-established and have received broad adoption, will help to drive revenues through 2015.

As the report explains, these developments underscore a broad, developing trend towards minimal access in neurosurgery.  The report also analyzes neurosurgical endoscopy, intracranial shunts, and surgical clips for aneurysm and AVMs.  Companies covered include Accuray, Aesculap (B. Braun), Boston Scientific, BrainLAB, Elekta, ev3, Integra LifeSciences, Johnson & Johnson, KARL STORZ Endoscopy, Medtronic, Micrus Endovascular, Terumo, and Varian Medical Systems, among others.

Immediate access to the Table of Contents for this report is available at:  lifescienceintelligence.com/market-reports-page.php?id=LSI-WW091NE

About Life Science Intelligence (LSI)®
LSI delivers high-quality market data and competitive intelligence to medical technology executives, entrepreneurs, and investors.  LSI produces the EMT (Emerging Medical Technologies)® Database, medtech market reports, and provides global custom research services, including market assessments and physician surveys.  www.LSintelligence.com.

Contact:
Life Science Intelligence
Scott Pantel, 1 714 847 3540
scott@LSintelligence.com